Please note: In October and November 2010, the MHRA moved from its Market Towers address to a new location on Buckingham Palace Road. Please go to the contact us section of the website for updated contact details.
Consultation ARM 61 sought your views on the reclassification from POM to P of domperidone 10 mg tablets (Motilium 10) for the additional indications of nausea and vomiting of less than 48 hours duration.
A total of 13 responses to the consultation were received, of which eight were in favour and five had no comment.
Pharmacy availability of domperidone for the treatment of nausea and vomiting of less than 48 hours duration supports self-care. Pharmacies are conveniently located and have more flexible opening hours, including at weekends.
Organisations supporting the reclassification
These included:
- medical colleges – Royal College of Physicians of Edinburgh
- pharmacy organisations – Royal Pharmaceutical Society of Great Britain (RPSGB)
Organisations not supporting the reclassification
None
Copies of the responses (excluding those marked as 'in confidence') are available below.
The following table summarises how pharmaceutical bodies, medical bodies and others responded to the consultation.
| Professional pharmaceutical societies, individual pharmacists, prescribing advisers and other pharmaceutical bodies |
|---|
|
Yes to proposal |
|
No comment
|
| Medical profession and royal colleges |
|---|
|
Yes to proposal |
|
No comment |
| Industry and trade associations |
|---|
|
Yes to proposal |
| Others |
|---|
|
Yes to proposal
|
